(Q33724339)

28 July 2017

1 reference

title

Defining the requirements for immunological control of mycobacterial infections (English)

1 reference

28 July 2017

1 reference

Murray PJ

1 reference

28 July 2017

publication date

1 September 1999

1 reference

28 July 2017

published in

Trends in Microbiology

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

366-372

1 reference

The protective immune response to Mycobacterium tuberculosis

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

An antimicrobial activity of cytolytic T cells mediated by granulysin

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Mycobacterium tuberculosis-driven processes in gene-disrupted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Increased antimycobacterial immunity in interleukin-10-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

A receptor for interleukin 10 is related to interferon receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

The role of TGF beta in the pathogenesis of human tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901567-X

7 January 2021

10.1016/S0966-842X(99)01567-X

Identifiers

DOI

1 reference

release_4hsdrlgulzfrpg73fjs6v3hese

28 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4hsdrlgulzfrpg73fjs6v3hese

24 November 2022

mapped directly with Wikidata item

1 reference